Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gun Ho Jang

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Nature Communications|June 20, 2024
In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancerSebastien Martinez, Shifei Wu, Michael Geuenich, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinomaKyaw L Aung, Elaine McWhirter, Stephen Welch, et al.
Nature|March 23, 2023
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancerAmina Jbara, Kuan-Ting Lin, Chani Stossel, et al.
Plos Computational Biology|January 11, 2019
Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancerDeena M A Gendoo, Robert E Denroche, Amy Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal AdenocarcinomaSheron Perera, Gun Ho Jang, Yifan Wang, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare SystemFelix E G Beaudry, Zhihao Li, Ayelet Borgida, et al.
Cell|October 13, 2021
Spatially confined sub-tumor microenvironments in pancreatic cancerBarbara T Grünwald, Antoine Devisme, Geoffroy Andrieux, et al.
Gut|September 16, 2020
Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinomaRobert C Grant, Robert Denroche, Gun Ho Jang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2024
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal AdenocarcinomaNaomi Yamamoto, Stephanie Dobersch, Ian Loveless, et al.
British Journal of Cancer|March 17, 2023
Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinomaLucy X Ma, Yifan Wang, Osvaldo Espin-Garcia, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Nature Communications|June 20, 2024
In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancerSebastien Martinez, Shifei Wu, Michael Geuenich, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinomaKyaw L Aung, Elaine McWhirter, Stephen Welch, et al.
Nature|March 23, 2023
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancerAmina Jbara, Kuan-Ting Lin, Chani Stossel, et al.
Plos Computational Biology|January 11, 2019
Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancerDeena M A Gendoo, Robert E Denroche, Amy Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal AdenocarcinomaSheron Perera, Gun Ho Jang, Yifan Wang, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare SystemFelix E G Beaudry, Zhihao Li, Ayelet Borgida, et al.
Cell|October 13, 2021
Spatially confined sub-tumor microenvironments in pancreatic cancerBarbara T Grünwald, Antoine Devisme, Geoffroy Andrieux, et al.
Gut|September 16, 2020
Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinomaRobert C Grant, Robert Denroche, Gun Ho Jang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2024
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal AdenocarcinomaNaomi Yamamoto, Stephanie Dobersch, Ian Loveless, et al.
British Journal of Cancer|March 17, 2023
Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinomaLucy X Ma, Yifan Wang, Osvaldo Espin-Garcia, et al.
Pageof 7